Seres Therapeutics, Inc. Forecasted to Earn Q1 2021 Earnings of ($0.29) Per Share (NASDAQ ...

Retrieved on: 2021-03-05 13:05:56

Tags for this article:

Click the tags to see associated articles and topics

Seres Therapeutics, Inc. Forecasted to Earn Q1 2021 Earnings of ($0.29) Per Share (NASDAQ .... View article details on hiswai:

Excerpt

BlackRock Inc. now owns 6,273,836 shares of the biotechnology company's stock worth $153,710,000 after acquiring an additional 252,551 shares ...

Article found on: www.marketbeat.com